Novel biochemical pathways of endoglin in vascular cell physiology

被引:98
作者
Bernabeu, Carmelo
Conley, Barbara A.
Vary, Calvin P. H.
机构
[1] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA
[2] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain
[3] Ctr Biomed Res Rare Dis CIBERER, Madrid 28040, Spain
关键词
endoglin; transforming growth factor-beta receptors; hereditary hemorrhagic telangiectasia; vascular pathology; vascular endothelium; vascular smooth muscle;
D O I
10.1002/jcb.21594
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The broad role of the transforming growth factor beta (TGFP) signaling pathway in vascular development, homeostasis, and repair is well appreciated. Endoglin is emerging as a novel, complex, and poorly understood regulatory component of the TGFP receptor complex, whose importance is underscored by its recognition as the site of mutations causing hereditary hemorrhagic telangiectasia (HHT) [McAllister et al., 1994]. Extensive analyses of endoglin function in normal developmental mouse models [Bourdeau et al., 1999; Li et al., 1999; Arthur et al., 2000] and in HHT animal models [Bourdeau et al., 2000; Torsney et al., 20031 exemplify the importance of understanding endoglin's biochemical functions. However, novel mechanisms underlying the regulation of these pathways continue to emerge. These mechanisms include modification of TGFP receptor signaling at the ligand and receptor activation level, direct effects of endoglin on cell adhesion and migration, and emerging roles for endoglin in the determination of stem cell fate and tissue patterning. The purpose of this review is to highlight the cellular and molecular studies that underscore the central role of endoglin in vascular development and disease. J. Cell. Biochem. 102: 1375-1388, 2007. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1375 / 1388
页数:14
相关论文
共 109 条
[1]  
AASSAR OS, 1991, LARYNGOSCOPE, V101, P977
[2]   Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease [J].
Abdalla, SA ;
Letarte, M .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (02) :97-110
[3]   Expression of endoglin mRNA and protein in human vascular smooth muscle cells [J].
Adam, PJ ;
Clesham, GJ ;
Weissberg, PL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :33-37
[4]   Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development [J].
Arthur, HM ;
Ure, J ;
Smith, AJH ;
Renforth, G ;
Wilson, DI ;
Torsney, E ;
Charlton, R ;
Parums, DV ;
Jowett, T ;
Marchuk, DA ;
Burn, J ;
Diamond, AG .
DEVELOPMENTAL BIOLOGY, 2000, 217 (01) :42-53
[5]   Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily [J].
Barbara, NP ;
Wrana, JL ;
Letarte, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :584-594
[6]   The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105) [J].
Barry, FP ;
Boynton, RE ;
Haynesworth, S ;
Murphy, JM ;
Zaia, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :134-139
[7]   IDENTIFICATION AND EXPRESSION OF 2 FORMS OF THE HUMAN TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN ENDOGLIN WITH DISTINCT CYTOPLASMIC REGIONS [J].
BELLON, T ;
CORBI, A ;
LASTRES, P ;
CALES, C ;
CEBRIAN, M ;
VERA, S ;
CHEIFETZ, S ;
MASSAGUE, J ;
LETARTE, M ;
BERNABEU, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2340-2345
[8]   Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? [J].
Berg, JN ;
Guttmacher, AE ;
Marchuk, DA ;
Porteous, MEM .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (03) :256-257
[9]   Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex [J].
Blanco, FJ ;
Santibanez, JF ;
Guerrero-Esteo, M ;
Langa, C ;
Vary, CPH ;
Bernabeu, C .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 204 (02) :574-584
[10]   Functional roles for the cytoplasmic domain of the type III transforming growth factor β receptor in regulating transforming growth factor β signaling [J].
Blobe, GC ;
Schiemann, WP ;
Pepin, MC ;
Beauchemin, M ;
Moustakas, A ;
Lodish, HF ;
O'Connor-McCourt, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24627-24637